NCT02097004View on ClinicalTrials.gov

Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

March 13, 2018

Conditions
Hepatitis B, Chronic
Interventions
BIOLOGICAL

Peginterferon alfa-2a

once weekly 180 μg subcutaneous injection for 48 weeks

BIOLOGICAL

HBV vaccination

1.0 mL (20 μg) intramuscular injection at 4, 8, 12 and 28 weeks

DRUG

Entecavir

Continue Entecavir(0.5mg) for 100 weeks

Trial Locations (1)

"ASI

Seoul National University, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02097004 - Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection | Biotech Hunter | Biotech Hunter